83:
36:
78:
138:
22:
17:
132:
119:
107:
61:
73:
95:
49:
35:
The following 8 pages are in this category, out of 8 total.
84:Discovery and development of direct Xa inhibitors
8:
37:This list may not reflect recent changes
32:Pages in category "Direct Xa inhibitors"
7:
41:
29:
14:
1:
79:Direct factor Xa inhibitors
155:
16:The main article for this
15:
23:Direct Xa inhibitor
146:
154:
153:
149:
148:
147:
145:
144:
143:
129:
128:
127:
126:
125:
124:
112:
100:
88:
66:
54:
28:
27:
12:
11:
5:
152:
150:
142:
141:
139:Anticoagulants
131:
130:
123:
122:
116:
113:
111:
110:
104:
101:
99:
98:
92:
89:
87:
86:
81:
76:
70:
67:
65:
64:
58:
55:
53:
52:
46:
43:
42:
33:
30:
13:
10:
9:
6:
4:
3:
2:
151:
140:
137:
136:
134:
121:
118:
117:
114:
109:
106:
105:
102:
97:
94:
93:
90:
85:
82:
80:
77:
75:
72:
71:
68:
63:
60:
59:
56:
51:
48:
47:
44:
40:
38:
31:
25:
24:
19:
34:
21:
120:Rivaroxaban
108:Otamixaban
62:Betrixaban
74:Darexaban
133:Category
96:Edoxaban
50:Apixaban
18:category
20:is
135::
39:.
115:R
103:O
91:E
69:D
57:B
45:A
26:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.